3-Bromo-5-methylpyridine → HCID 67319709, compound
Reaction equation
CC1(C)C(C)(C)OB([C:9]2[CH:14]=[CH:13][C:12]([C@@H:15]3[CH2:17][C@H:16]3[NH:18][S:19]([CH:22]([CH3:24])[CH3:23])(=[O:21])=[O:20])=[CH:11][CH:10]=2)O1.Br[C:27]1[CH:28]=[N:29][CH:30]=[C:31]([CH3:33])[CH:32]=1>>[CH3:33][C:31]1[CH:32]=[C:27]([C:9]2[CH:10]=[CH:11][C:12]([C@@H:15]3[CH2:17][C@H:16]3[NH:18][S:19]([CH:22]([CH3:23])[CH3:24])(=[O:20])=[O:21])=[CH:13][CH:14]=2)[CH:28]=[N:29][CH:30]=1Participants
3
Procedure
Example 11 was prepared from trans-N-{2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclopropyl}-2-propanesulfonamide (Intermediate 8) (69 mg, 0.189 mmol) and 3-bromo-5-methylpyridine (65 mg, 0.378 mmol) according to a similar procedure as for Example 10.
Sources & evidence
- ORD record
- ord-699c9fb9481243cca69539c7ae15df5f
- Source dataset
- uspto-grants-2010_09
- Patent number
- US07790758B2
Reaction notes
Loading…